Indeed, the benefit for already-born people is harder to forsee. That depends on more-distant biotech innovations. It could be that they come quickly (making embryo interventions less relevant) or slowly (making embryo interventions very important).
Indeed, the benefit for already-born people is harder to forsee. That depends on more-distant biotech innovations. It could be that they come quickly (making embryo interventions less relevant) or slowly (making embryo interventions very important).